#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10760	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2051	516.2	0	.	n	.	0	C451T	SNP	451	451	C	663	663	T	637	T,C	327,297	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10760	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2051	516.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1396	1396	C	578	C	572	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10760	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2051	516.2	0	HET	.	.	.	C207T	.	207	207	C	419	419	C	609	C,T	461,139	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19546	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3556	544.5	0	.	n	.	0	T695C	SNP	695	695	T	1049	1049	C	577	C,G	569,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19546	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3556	544.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2325	2325	C	585	C,G,A	571,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19546	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3556	544.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2399	2399	A	629	A	614	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19546	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3556	544.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2951	2951	C	610	C	596	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19546	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3556	544.5	0	HET	.	.	.	A1638G	.	1638	1638	A	1992	1992	A	644	A,G	482,151	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	12	blaTEM	861	333	99.7	blaTEM.l15.c30.ctg.1	333	2.1	0	.	p	.	0	H110D	NONSYN	328	330	CAT	281	283	GAT	3;3;3	G,C;A;T	0,3;3;3	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1332	folP	855	855	100.0	folP.l15.c4.ctg.1	1710	77.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1106	1108	AGC	132;132;133	A;G;C	130;128;130	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3624	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3444	103.8	1	SNP	p	S91F	1	.	.	271	273	TTC	564	566	TTC	128;128;130	T;T;C	126;126;125	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3624	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3444	103.8	1	SNP	p	D95G	1	.	.	283	285	GGC	576	578	GGC	116;118;117	G;G;C	112;113;112	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3624	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3444	103.8	1	SNP	p	G95N	0	.	.	283	285	GGC	576	578	GGC	116;118;117	G;G;C	112;113;112	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1116	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1348	82.0	1	SNP	p	G45D	0	.	.	133	135	GGC	477	479	GGC	120;119;119	G;G;C	120;117;117	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	616	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	969	63.1	0	.	n	.	0	A197.	DEL	197	197	A	622	622	A	127	A	125	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3526	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	118.7	1	SNP	p	D86N	0	.	.	256	258	GAC	609	611	GAC	140;137;138	G;A,G;C,G	135;130,1;134,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3526	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	118.7	1	SNP	p	R87W	0	.	.	259	261	CGT	612	614	CGT	138;140;141	C;G,A;T	136;135,1;132	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3526	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	118.7	1	SNP	p	S87R	1	.	.	259	261	CGT	612	614	CGT	138;140;141	C;G,A;T	136;135,1;132	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3526	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	118.7	1	SNP	p	R87I	0	.	.	259	261	CGT	612	614	CGT	138;140;141	C;G,A;T	136;135,1;132	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3526	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2941	118.7	1	SNP	p	S88P	0	.	.	262	264	TCC	615	617	TCC	142;143;140	T;C;C	137;140;134	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2786	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2733	100.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1582	1584	GGC	153;152;154	G;G;C	146;147;148	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1217	1219	GCC	152;154;153	G;C;C	144;147;145	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1220	1222	ATG	153;152;153	A;T;G,A,T	144;144;141,1,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1232	1234	ACC	153;155;159	A;C,T;C	144;148,1;153	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1232	1234	ACC	153;155;159	A;C,T;C	144;148,1;153	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1733	1735	ACC	123;122;124	A;C;C	116;121;120	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1787	1789	GCG	122;122;124	G;C,T;G	119;117,1;120	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1787	1789	GCG	122;122;124	G;C,T;G	119;117,1;120	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1910	1912	GGT	90;90;90	G;G;T	84;84;84	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1919	1921	AGC	87;87;87	A;G;C	78;82;81	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2362	114.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1937	1939	CCG	74;74;75	C,G;C,G,A;G	65,3;67,1,1;64	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4100	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3195	126.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1711	1713	CCG	131;132;131	C,G;C;G	120,1;124;124	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1718	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1773	95.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	542	542	C	133	C	128	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	196	porB1a	984	285	90.66	porB1a.l15.c30.ctg.1	361	19.3	0	.	p	.	0	V212L	NONSYN	634	636	GTC	86	88	CTC	12;12;12	C,G;T;C	0,11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	196	porB1a	984	285	90.66	porB1a.l15.c30.ctg.1	361	19.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	101	103	AAT	11;11;11	A;A;T	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	196	porB1a	984	285	90.66	porB1a.l15.c30.ctg.1	361	19.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	104	106	AAT	11;11;11	A;A;T	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	196	porB1a	984	285	90.66	porB1a.l15.c30.ctg.1	361	19.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	128	130	GCA	10;10;10	G;C;A	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	196	porB1a	984	285	90.66	porB1a.l15.c30.ctg.1	361	19.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	151	153	GTA	11;11;11	G;T;A	11;10;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	196	porB1a	984	285	90.66	porB1a.l15.c30.ctg.1	361	19.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	160	160	A	9	A	9	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1992	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1461	133.8	1	SNP	p	G120K	1	.	.	358	360	AAG	647	649	AAG	144;143;145	A,C;A;G,A	134,2;140;131,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1992	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1461	133.8	1	SNP	p	N121D	0	.	.	361	363	AAC	650	652	AAC	148;149;148	A,G;A;C	141,1;144;140	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1992	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1461	133.8	1	SNP	p	A121N	1	.	.	361	363	AAC	650	652	AAC	148;149;148	A,G;A;C	141,1;144;140	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7106	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4913	143.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	852	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1129	74.6	1	SNP	p	V57M	1	.	.	169	171	ATG	633	635	ATG	156;157;159	A;T;G	153;155;156	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
